论文部分内容阅读
摘要目的评估经皮射频消融在治疗单功能肾病人肾小肿瘤的长期疗效。方法这是一个单中心的前瞻性研究。单功能肾且肾肿瘤<3.5 cm,并接受射频消融治疗超过7.5年的病人纳入分析。连续19例(男性12例)病人,年龄在33~83岁之间(平均61.4岁),共23个病灶接受了治疗。主要关注点是技术的成功和肿瘤复发率,次要关注点是肾功能恶化及总的成活率。结果平均随访时间为56.1个月(36~102个月),主要技术成功率为100%,没有严重的围手术期并发症,
Abstract Objective To evaluate the long-term efficacy of percutaneous radiofrequency ablation (RFA) in the treatment of renal small tumors of single-function nephropathy. This is a single-center, prospective study. Single-function renal and renal tumors <3.5 cm and were included in the analysis of patients who underwent radiofrequency ablation for more than 7.5 years. Twenty-nine consecutive patients (12 males) were aged 33 to 83 years (mean, 61.4 years). A total of 23 lesions were treated. The main concern is the technical success and tumor recurrence rate, the secondary concern is the deterioration of renal function and the overall survival rate. Results The average follow-up time was 56.1 months (36-102 months). The main technical success rate was 100%. There was no serious perioperative complications,